{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:43:57Z","timestamp":1778219037935,"version":"3.51.4"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ejphar.2020.173507","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T12:22:25Z","timestamp":1598358145000},"page":"173507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"special_numbering":"C","title":["MicroRNA interplay between hepatic stellate cell quiescence and activation"],"prefix":"10.1016","volume":"885","author":[{"given":"Devaraj","family":"Ezhilarasan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173507_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.virusres.2018.06.007","article-title":"miRNA-221 and miRNA-222 are promising biomarkers for progression of liver fibrosis in HCV Egyptian patients","volume":"253","author":"Abdel-Al","year":"2018","journal-title":"Virus Res."},{"key":"10.1016\/j.ejphar.2020.173507_bib2","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.ajpath.2014.01.016","article-title":"Protein tyrosine phosphatase \u03b1 mediates profibrotic signaling in lung fibroblasts through TGF-\u03b2 responsiveness","volume":"184","author":"Aschner","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2020.173507_bib3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhep.2014.10.004","article-title":"miR-122--a key factor and therapeutic target in liver disease","volume":"62","author":"Bandiera","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2020.173507_bib4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/ijms17010078","article-title":"Circulating MicroRNAs as biomarkers for sepsis","volume":"17","author":"Benz","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2020.173507_bib5","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1002\/hep.29627","article-title":"MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis","volume":"67","author":"Caviglia","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2020.173507_bib6","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1111\/jcmm.13278","article-title":"MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy","volume":"21","author":"Chen","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2020.173507_bib7","doi-asserted-by":"crossref","first-page":"G491","DOI":"10.1152\/ajpgi.00140.2015","article-title":"Suppression of fibrogenic signaling in hepatic stellate cells by Twist1-dependent microRNA-214 expression: role of exosomes in horizontal transfer of Twist1","volume":"309","author":"Chen","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejphar.2020.173507_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2217\/epi-2019-0104","article-title":"miRNA-150-5p promotes hepatic stellate cell proliferation and sensitizes hepatocyte apoptosis during liver fibrosis","volume":"12","author":"Chen","year":"2020","journal-title":"Epigenomics"},{"key":"10.1016\/j.ejphar.2020.173507_bib9","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1096\/fj.201902307RRR","article-title":"Exosomal miR-103-3p from LPS-activated THP-1 macrophage contributes to the activation of hepatic stellate cells","volume":"34","author":"Chen","year":"2020","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejphar.2020.173507_bib10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41419-020-2613-y","article-title":"Synergistic antifibrotic effects of miR-451 with miR-185 partly by co-targeting EphB2 on hepatic stellate cells","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2020.173507_bib11","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1053\/j.gastro.2012.07.115","article-title":"Hedgehog controls hepatic stellate cell fate by regulating metabolism","volume":"143","author":"Chen","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2020.173507_bib12","first-page":"284","article-title":"MicroRNA-122 inhibits epithelial-mesenchymal transition of hepatic stellate cells induced by the TGF-\u03b21\/Smad signaling pathway","volume":"17","author":"Cheng","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejphar.2020.173507_bib13","doi-asserted-by":"crossref","first-page":"G39","DOI":"10.1152\/ajpgi.00263.2007","article-title":"Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis","volume":"294","author":"Cheng","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejphar.2020.173507_bib14","series-title":"Nanoparticles and Their Biomedical Applications","first-page":"45","article-title":"Nanomedicine for hepatic fibrosis","author":"Devaraj","year":"2020"},{"key":"10.1016\/j.ejphar.2020.173507_bib15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1535370219898141","article-title":"Mechanisms of liver fibrosis and its role in liver cancer","volume":"245","author":"Dhar","year":"2020","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.ejphar.2020.173507_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ajg.2018.03.002","article-title":"Oxidative stress is bane in chronic liver diseases: clinical and experimental perspective","volume":"19","author":"Ezhilarasan","year":"2018","journal-title":"Arab J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2020.173507_bib17","first-page":"174","article-title":"Role of MicroRNAs in hepatic fibrosis progression","volume":"8","author":"Ezhilarasan","year":"2018","journal-title":"J. Appl. Pharmaceut. Sci."},{"key":"10.1016\/j.ejphar.2020.173507_bib18","series-title":"Phytochemicals as Lead Compounds for New Drug Discovery: Recent Advances","first-page":"195","article-title":"Lead compounds with the potentials for the treatment of chronic liver diseases","author":"Ezhilarasan","year":"2019"},{"key":"10.1016\/j.ejphar.2020.173507_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/1535370220949148","article-title":"Endothelin -1 in portal hypertension: the intricate role of hepatic stellate cells","author":"Ezhilarasan","year":"2020","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.ejphar.2020.173507_bib21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.hbpd.2018.04.003","article-title":"Hepatic fibrosis: it is time to go with hepatic stellate cell-specific therapeutic targets","volume":"17","author":"Ezhilarasan","year":"2018","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.ejphar.2020.173507_bib22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.ejphar.2020.173507_bib23","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jhep.2017.06.001","article-title":"Hepatic stellate cell activation and pro-fibrogenic signals","volume":"67","author":"Gandhi","year":"2017","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.ejphar.2020.173507_bib24","first-page":"918","article-title":"MicroRNA-146b regulates hepatic stellate cell activation via targeting of KLF4","volume":"15","author":"Ge","year":"2016","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.ejphar.2020.173507_bib25","doi-asserted-by":"crossref","first-page":"8541","DOI":"10.1038\/s41598-019-44865-1","article-title":"Overexpression of miRNA-25-3p inhibits Notch1 signaling and TGF-\u03b2-induced collagen expression in hepatic stellate cells","volume":"9","author":"Genz","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2020.173507_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/cbin.11075","article-title":"MicroRNA-1254 contributes to the controlling of pro-fibrogenic environment in LX-2 cells by modulating SMAD3 and wound repair: new insights in hepatic fibrosis","volume":"43","author":"Gon\u00e7alves","year":"2019","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.ejphar.2020.173507_bib27","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep4.1356","article-title":"Liver macrophages: old dogmas and new insights","volume":"3","author":"Guillot","year":"2019","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.ejphar.2020.173507_bib28","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1074\/mcp.RA117.000504","article-title":"Proteotranscriptomic measurements of E6-associated protein (E6AP) targets in DU145 prostate cancer cells","volume":"17","author":"Gulati","year":"2018","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ejphar.2020.173507_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214534","article-title":"TGF-\u03b2 induces liver fibrosis via miRNA-181a-mediated down regulation of augmenter of liver regeneration in hepatic stellate cells","volume":"14","author":"Gupta","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2020.173507_bib30","doi-asserted-by":"crossref","first-page":"158674","DOI":"10.1016\/j.bbalip.2020.158674","article-title":"Retinoids in health and disease: a role for hepatic stellate cells in affecting retinoid levels","volume":"1865","author":"Haaker","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.ejphar.2020.173507_bib31","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.cellsig.2012.06.003","article-title":"MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4","volume":"24","author":"He","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2020.173507_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejphar.2020.173507_bib33","first-page":"203","article-title":"miR-125b-5p inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma via targeting TXNRD1","volume":"19","author":"Hua","year":"2019","journal-title":"Canc. Cell Int."},{"key":"10.1016\/j.ejphar.2020.173507_bib34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3389\/fphar.2019.00431","article-title":"Interaction mechanisms between the NOX4\/ROS and RhoA\/ROCK1 signaling pathways as new anti- fibrosis targets of ursolic acid in hepatic stellate cells","volume":"10","author":"Huang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173507_bib35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.canlet.2020.02.012","article-title":"Hepatic stellate cells promote the progression of hepatocellular carcinoma through microRNA-1246-ROR\u03b1-Wnt\/\u03b2-Catenin axis","volume":"476","author":"Huang","year":"2020","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejphar.2020.173507_bib36","doi-asserted-by":"crossref","first-page":"212","DOI":"10.7150\/ijms.29930","article-title":"MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation","volume":"16","author":"Huang","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.ejphar.2020.173507_bib37","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1038\/ncomms10993","article-title":"MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression","volume":"7","author":"Hyun","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2020.173507_bib38","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1002\/jcb.27746","article-title":"MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7","volume":"120","author":"Ji","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2020.173507_bib39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13578-017-0161-7","article-title":"The roles of microRNA families in hepatic fibrosis","volume":"7","author":"Jiang","year":"2017","journal-title":"Cell Biosci."},{"key":"10.1016\/j.ejphar.2020.173507_bib40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/hum.2018.047","article-title":"Artificial MicroRNA-mediated Tgfbr2 and pdgfrb Co-silencing ameliorates carbon tetrachloride-induced hepatic fibrosis in mice","volume":"30","author":"Jiang","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ejphar.2020.173507_bib41","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3390\/ijms20040796","article-title":"MicroRNA29a reverts the activated hepatic stellate cells in the regression of hepatic fibrosis through regulation of ATPase H\u207a transporting V1 subunit C1","volume":"20","author":"Jing","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2020.173507_bib42","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1111\/jcmm.14210","article-title":"miR-193a\/b-3p relieves hepatic fibrosis and restrains proliferation and activation of hepatic stellate cells","volume":"23","author":"Ju","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2020.173507_bib43","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41598-019-57322-w","article-title":"Induction of E6AP by microRNA-302c dysregulation inhibits TGF-\u03b2-dependent fibrogenesis in hepatic stellate cells","volume":"10","author":"Kim","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2020.173507_bib44","doi-asserted-by":"crossref","first-page":"990","DOI":"10.4252\/wjsc.v11.i11.990","article-title":"Ameliorating liver fibrosis in an animal model using the secretome released from miR-122-transfected adipose-derived stem cells","volume":"11","author":"Kim","year":"2019","journal-title":"World J. Stem Cell."},{"key":"10.1016\/j.ejphar.2020.173507_bib45","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/jcm5030038","article-title":"Hepatic stellate cells and microRNAs in pathogenesis of liver fibrosis","volume":"5","author":"Kitano","year":"2016","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejphar.2020.173507_bib46","doi-asserted-by":"crossref","first-page":"116902","DOI":"10.1016\/j.lfs.2019.116902","article-title":"The lncRNA NEAT1\/miR-29b\/Atg9a axis regulates IGFBPrP1-induced autophagy and activation of mouse hepatic stellate cells","volume":"237","author":"Kong","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2020.173507_bib47","article-title":"MicroRNA-489-3p represses hepatic stellate cells activation by negatively regulating the JAG1\/notch3 signaling pathway","author":"Li","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejphar.2020.173507_bib49","doi-asserted-by":"crossref","first-page":"172787","DOI":"10.1016\/j.ejphar.2019.172787","article-title":"ZEB1 regulates the activation of hepatic stellate cells through Wnt\/\u03b2-catenin signaling pathway","volume":"865","author":"Li","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173507_bib48","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4254\/wjh.v11.i5.412","article-title":"Roles of hepatic stellate cells in acute liver failure: from the perspective of inflammation and fibrosis","volume":"11","author":"Li","year":"2019","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.ejphar.2020.173507_bib50","first-page":"406","article-title":"Downregulation of miR-141 deactivates hepatic stellate cells by targeting the PTEN\/AKT\/mTOR pathway","volume":"46","author":"Liang","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejphar.2020.173507_bib51","doi-asserted-by":"crossref","first-page":"9569","DOI":"10.18632\/aging.102405","article-title":"TGF-\u03b2- and lipopolysaccharide-induced upregulation of circular RNA PWWP2A promotes hepatic fibrosis via sponging miR-203 and miR-223","volume":"11","author":"Liu","year":"2019","journal-title":"Aging"},{"key":"10.1016\/j.ejphar.2020.173507_bib52","doi-asserted-by":"crossref","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","article-title":"Hepatocellular carcinoma","volume":"2","author":"Llovet","year":"2016","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.ejphar.2020.173507_bib53","first-page":"1543","article-title":"MicroRNA-219 overexpression serves a protective role during liver fibrosis by targeting tumor growth factor \u03b2 receptor 2","volume":"19","author":"Ma","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2020.173507_bib54","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41419-018-0752-1","article-title":"MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression","volume":"9","author":"Ma","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2020.173507_bib55","doi-asserted-by":"crossref","first-page":"40468","DOI":"10.1038\/srep40468","article-title":"MircoRNA-145 promotes activation of hepatic stellate cells via targeting kr\u00fcppel-like factor 4","volume":"7","author":"Men","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2020.173507_bib56","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.3390\/nu11112597","article-title":"mir-101-3p downregulation promotes fibrogenesis by facilitating hepatic stellate cell transdifferentiation during insulin resistance","volume":"11","author":"Meroni","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2020.173507_bib57","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/jcmm.13465","article-title":"Emerging role of Twist1 in fibrotic diseases","volume":"22","author":"Ning","year":"2018","journal-title":"J. Cell Mol. Med."},{"issue":"10","key":"10.1016\/j.ejphar.2020.173507_bib58","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.3390\/ijms19103103","article-title":"Wnt\/\u03b2-Catenin signaling as a potential target for the treatment of liver cirrhosis using antifibrotic drugs","volume":"19","author":"Nishikawa","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2020.173507_bib59","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1136\/gutjnl-2011-300717","article-title":"MicroRNA-221\/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis","volume":"61","author":"Ogawa","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2020.173507_bib60","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2020.173507_bib61","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s12072-019-09993-w","article-title":"MicroRNA-744\/transforming growth factor \u03b21 relationship regulates liver cirrhosis","volume":"13","author":"Ren","year":"2019","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ejphar.2020.173507_bib62","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","article-title":"Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis","volume":"53","author":"Roderburg","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2020.173507_bib63","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/ijms19010261","article-title":"The role of miRNAs in the pathophysiology of liver diseases and toxicity","volume":"19","author":"Schueller","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2020.173507_bib64","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00535-017-1404-4","article-title":"Human hepatic stellate cell isolation and characterization","volume":"53","author":"Shang","year":"2018","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2020.173507_bib65","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev-cellbio-100617-062855","article-title":"Stellate cells in tissue repair, inflammation, and cancer","volume":"34","author":"Sherman","year":"2018","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2020.173507_bib66","doi-asserted-by":"crossref","first-page":"1945631","DOI":"10.1155\/2017\/1945631","article-title":"MicroRNA-195 activates hepatic stellate cells in vitro by targeting Smad7","volume":"2017","author":"Song","year":"2017","journal-title":"BioMed Res. Int."},{"issue":"1","key":"10.1016\/j.ejphar.2020.173507_bib67","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/14728214.2020.1735350","article-title":"Novel targeted therapies for the management of liver fibrosis","volume":"25","author":"Trivella","year":"2020","journal-title":"Expet Opin. Emerg. Drugs"},{"key":"10.1016\/j.ejphar.2020.173507_bib68","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2020.173507_bib69","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/jcmm.14750","article-title":"microRNA-143-3p attenuated development of hepatic fibrosis in autoimmune hepatitis through regulation of TAK1 phosphorylation","volume":"24","author":"Tu","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2020.173507_bib70","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/path.4373","article-title":"MicroRNA-101 suppresses liver fibrosis by targeting the TGF\u03b2 signalling pathway","volume":"234","author":"Tu","year":"2014","journal-title":"J. Pathol."},{"key":"10.1016\/j.ejphar.2020.173507_bib71","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.3389\/fimmu.2019.02852","article-title":"Therapeutic targeting of hepatic macrophages for the treatment of liver diseases","volume":"10","author":"van der Heide","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2020.173507_bib72","doi-asserted-by":"crossref","first-page":"G101","DOI":"10.1152\/ajpgi.00220.2009","article-title":"Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation","volume":"298","author":"Venugopal","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejphar.2020.173507_bib73","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1139\/bcb-2018-0211","article-title":"MicroRNA-134 deactivates hepatic stellate cells by targeting TGF-\u03b2 activated kinase 1-binding protein 1","volume":"97","author":"Wang","year":"2019","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.ejphar.2020.173507_bib74","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3389\/fcell.2020.00513","article-title":"MicroRNA-98 inhibits hepatic stellate cell activation and attenuates liver fibrosis by regulating HLF expression","volume":"8","author":"Wang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2020.173507_bib75","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.omtn.2019.05.001","article-title":"miR-455-3p alleviates hepatic stellate cell activation and liver fibrosis by suppressing HSF1 expression","volume":"16","author":"Wei","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejphar.2020.173507_bib76","doi-asserted-by":"crossref","first-page":"1801809","DOI":"10.1002\/advs.201801809","article-title":"Synergistic MicroRNA therapy in liver fibrotic rat using MRI-visible nanocarrier targeting hepatic stellate cells","volume":"6","author":"Wu","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejphar.2020.173507_bib77","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3349\/ymj.2019.60.6.561","article-title":"miR-140-3p knockdown suppresses cell proliferation and fibrogenesis in hepatic stellate cells via PTEN-mediated AKT\/mTOR signaling","volume":"60","author":"Wu","year":"2019","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.ejphar.2020.173507_bib78","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.3748\/wjg.v25.i31.4468","article-title":"MicroRNA-194 inactivates hepatic stellate cells and alleviates liver fibrosis by inhibiting AKT2","volume":"25","author":"Wu","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2020.173507_bib79","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/hep.26511","article-title":"Cross-talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice","volume":"58","author":"Xie","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2020.173507_bib80","article-title":"MicroRNA-503 targets mothers against decapentaplegic homolog 7 enhancing hepatic stellate cell activation and hepatic fibrosis","author":"Xie","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejphar.2020.173507_bib81","doi-asserted-by":"crossref","first-page":"172927","DOI":"10.1016\/j.ejphar.2020.172927","article-title":"MicroRNA-708 represses hepatic stellate cells activation and proliferation by targeting ZEB1 through Wnt\/\u03b2-catenin pathway","volume":"871","author":"Yang","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173507_bib82","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1053\/jhep.2001.23901","article-title":"Ca2+ and rho signaling pathways: two paths to hepatic stellate cell contraction","volume":"33","author":"Yee","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2020.173507_bib83","first-page":"1707","article-title":"Identification of miRNAs associated with the mechanical response of hepatic stellate cells by miRNA microarray analysis","volume":"16","author":"Yi","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejphar.2020.173507_bib84","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.omtn.2018.04.016","article-title":"MicroRNA-125b promotes hepatic stellate cell activation and liver fibrosis by activating RhoA signaling","volume":"12","author":"You","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejphar.2020.173507_bib85","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1667\/RR15401.1","article-title":"MicroRNA-146a-5p attenuates fibrosis-related molecules in irradiated and TGF-beta1-treated human hepatic stellate cells by regulating PTPRA-SRC signaling","volume":"192","author":"Yuan","year":"2019","journal-title":"Radiat. Res."},{"key":"10.1016\/j.ejphar.2020.173507_bib86","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fmed.2020.00007","article-title":"Critical role of microRNA-21 in the pathogenesis of liver diseases","volume":"7","author":"Zhang","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.ejphar.2020.173507_bib87","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.trsl.2019.07.007","article-title":"siRNA- and miRNA-based therapeutics for liver fibrosis","volume":"214","author":"Zhao","year":"2019","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejphar.2020.173507_bib88","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000488411","article-title":"MicroRNA-30a suppresses the activation of hepatic stellate cells by inhibiting epithelial-to-mesenchymal transition","volume":"46","author":"Zheng","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejphar.2020.173507_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2019.01.012","article-title":"MiR-146a attenuates liver fibrosis by inhibiting transforming growth factor-\u03b21 mediated epithelial-mesenchymal transition in hepatocytes","volume":"58","author":"Zou","year":"2019","journal-title":"Cell. Signal."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920305999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920305999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:10:44Z","timestamp":1762143044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920305999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":88,"alternative-id":["S0014299920305999"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173507","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA interplay between hepatic stellate cell quiescence and activation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173507"}}